LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Y39983 | 1.11 | uM | LJP6 | 72 | hr | 1657 | 4677 | 5383 | 0.8690 | 0.8415 |
BT-20 | Y39983 | 3.33 | uM | LJP6 | 72 | hr | 1657 | 4304 | 5383 | 0.7999 | 0.7537 |
BT-20 | Y39983 | 10 | uM | LJP6 | 72 | hr | 1657 | 2245 | 5383 | 0.4168 | 0.1941 |
BT-20 | Nintedanib | 0.04 | uM | LJP6 | 72 | hr | 1657 | 5730 | 5383 | 1.0648 | 1.0755 |
BT-20 | Nintedanib | 0.12 | uM | LJP6 | 72 | hr | 1657 | 5735 | 5383 | 1.0657 | 1.0767 |
BT-20 | Nintedanib | 0.37 | uM | LJP6 | 72 | hr | 1657 | 5330 | 5383 | 0.9903 | 0.9889 |
BT-20 | Nintedanib | 1.11 | uM | LJP6 | 72 | hr | 1657 | 4810 | 5383 | 0.8940 | 0.8723 |
BT-20 | Nintedanib | 3.33 | uM | LJP6 | 72 | hr | 1657 | 4432 | 5383 | 0.8231 | 0.7832 |
BT-20 | Nintedanib | 10 | uM | LJP6 | 72 | hr | 1657 | 3332 | 5383 | 0.6188 | 0.5071 |
BT-20 | Foretinib | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5724 | 5588 | 1.0245 | 1.0279 |
BT-20 | Foretinib | 0.12 | uM | LJP5 | 72 | hr | 1657 | 4719 | 5588 | 0.8446 | 0.8163 |
BT-20 | Foretinib | 0.37 | uM | LJP5 | 72 | hr | 1657 | 3174 | 5588 | 0.5681 | 0.4478 |
BT-20 | Foretinib | 1.11 | uM | LJP5 | 72 | hr | 1657 | 1764 | 5588 | 0.3158 | 0.0363 |
BT-20 | Foretinib | 3.33 | uM | LJP5 | 72 | hr | 1657 | 1624 | 5588 | 0.2907 | -0.0116 |
BT-20 | Foretinib | 10 | uM | LJP5 | 72 | hr | 1657 | 1525 | 5588 | 0.2731 | -0.0468 |
BT-20 | AZD 5438 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 5047 | 5383 | 0.9378 | 0.9260 |
BT-20 | AZD 5438 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 3913 | 5383 | 0.7271 | 0.6580 |
BT-20 | AZD 5438 | 0.37 | uM | LJP6 | 72 | hr | 1657 | 2629 | 5383 | 0.4882 | 0.3110 |
BT-20 | AZD 5438 | 1.11 | uM | LJP6 | 72 | hr | 1657 | 1829 | 5383 | 0.3401 | 0.0598 |
BT-20 | AZD 5438 | 3.33 | uM | LJP6 | 72 | hr | 1657 | 1657 | 5383 | 0.3076 | -0.0015 |
BT-20 | AZD 5438 | 10 | uM | LJP6 | 72 | hr | 1657 | 1023 | 5383 | 0.1902 | -0.2473 |
BT-20 | Pelitinib | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5675 | 5588 | 1.0155 | 1.0176 |
BT-20 | Pelitinib | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5301 | 5588 | 0.9488 | 0.9409 |
BT-20 | Pelitinib | 0.37 | uM | LJP5 | 72 | hr | 1657 | 4531 | 5588 | 0.8108 | 0.7744 |
BT-20 | Pelitinib | 1.11 | uM | LJP5 | 72 | hr | 1657 | 4369 | 5588 | 0.7818 | 0.7378 |